PMC9742504_01
Radiologic follow-up of patients who experienced disease burden reduction after COVID-19. In blue frames, representative basal CT scans after recovery from COVID-19; in green frames, CT scans at last follow-up or progression. Patient#1. CT scans show absence of liver metastases (section 2 versus section 1). Patient#2. CT scans in green frame show a residual cystic area (section 2) after surgical removal of the lesion at segment VII (section 1) but a new metastatic liver lesions at segment VI (section 3) with the relative measures (16 x 19 mm) (August 2020). Patient#3. Sections 3 and 4 evidence both new and increased size nodules on the peritoneum surface compared to basal sections (1 and 2) (relative measures are reported into the images).. COVID-19, coronavirus disease 19; CT, computed tomography.
10.1177_17588359221138388-fig1.jpg
PMC9742504_01_10.1177_17588359221138388-fig1.jpg
fig1-17588359221138388
At last follow-up (June 2022), there was no progression of disease at any site; the liver was persistently free from disease (Figure 1). At last follow-up (July 2022), there was disappearance of segment VII (where an area resembling a residual cyst was evidenced) but a new lesion (17 x 18 mm) at segment VI (Figure 1). In December 2021, she presented progression of disease because of new lesions and increased size of pre-existing measurable nodules on the peritoneum surface (Figure 1).